Nasopharyngitis

Summary

Nasopharyngitis (MONDO:0001040) is a disease and 3 clinical trials. A subtype of nasopharyngeal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	nasopharyngitis
Mondo ID	MONDO:0001040
MeSH	D009304
DOID	DOID:10460
NCIT	C34837
SNOMED CT	47841006
UMLS	C0027441
MedGen	6527
Is cancer (heuristic)	no

Also known as: inflammation of nasopharynx · nasopharynx inflammation

Disease family

An umbrella term covering 2 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › upper respiratory tract disorder › nasopharyngeal disorder › nasopharyngitis

Related subtypes (2): nasopharyngeal neoplasm, nasopharyngeal diphtheria

Subtypes (2): adenoiditis, common cold

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE4	1
PHASE2	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04797936	PHASE4	COMPLETED	BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19
NCT06843018	PHASE2	RECRUITING	Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges
NCT07568548	Not specified	NOT_YET_RECRUITING	Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Chronic Nasopharyngitis